Influence of Acellular Dermal Matrix on Peri-implant Soft Tissue Phenotype and Marginal Bone Loss

Influence of Acellular Dermal Matrix on Peri-implant Soft Tissue Phenotype and Marginal Bone Loss Following Immediate Implant Placement in Anterior Maxilla: A Randomized Controlled Clinical Trial

To evaluate soft tissue augmentation using acellular dermal matrix (ADM) over immediately placed dental implants in anterior maxilla.

This randomized clinical trial was designed to evaluate and compare the efficacy of ADM versus d-PTFE membranes in the preservation of the peri-implant hard and soft tissues in the setting of immediate implant placement on the anterior maxilla.

Inclusion Criteria:

• Patients with non-restorable maxillary anterior tooth/teeth.
• Good oral hygiene.
• Patients' cooperation and fully capable to comply with the study protocol.
• Age ranges from 18 to 45 years.
• Free from history of parafunctional habits e.g. clenching and bruxism
• Sufficient inter- arch space.

Exclusion Criteria:

• Any local pathological condition that contraindicates implant placement.
• Pregnancy.
• Medication that affects bone healing.
• Psychological problems.
• Patient had undergone radiation therapy to the head and neck area in the past 12 months.